Furthermore, the miR-30a-5p/CLCF1 axis has been implicated in regulating sorafenib resistance by directly targeting CLCF1, modulating PI3K/Akt signaling, and attenuating aerobic glycolysis in sorafenib-resistant HCC cells [376]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.